PHQ-9, CES-D, health insurance data—who is identified with depression? A Population-based study in persons with diabetes
Tóm tắt
Several instruments are used to identify depression among patients with diabetes and have been compared for their test criteria, but, not for the overlaps and differences, for example, in the sociodemographic and clinical characteristics of the individuals identified with different instruments. We conducted a cross-sectional survey among a random sample of a statutory health insurance (SHI) (n = 1,579) with diabetes and linked it with longitudinal SHI data. Depression symptoms were identified using either the Centre for Epidemiological Studies Depression (CES-D) scale or the Patient Health Questionnaire-9 (PHQ-9), and a depressive disorder was identified with a diagnosis in SHI data, resulting in 8 possible groups. Groups were compared using a multinomial logistic model. In total 33·0% of our analysis sample were identified with depression by at least one method. 5·0% were identified with depression by all methods. Multinomial logistic analysis showed that identification through SHI data only compared to the group with no depression was associated with gender (women). Identification through at least SHI data was associated with taking antidepressants and previous depression. Health related quality of life, especially the mental summary score was associated with depression but not when identified through SHI data only. The methods overlapped less than expected. We did not find a clear pattern between methods used and characteristics of individuals identified. However, we found first indications that the choice of method is related to specific underlying characteristics in the identified population. These findings need to be confirmed by further studies with larger study samples.
Tài liệu tham khảo
Harding KA, Pushpanathan ME, Whitworth SR, Nanthakumar S, Bucks RS, Skinner TC. Depression prevalence in type 2 diabetes is not related to diabetes–depression symptom overlap but is related to symptom dimensions within patient self-report measures: a meta‐analysis. Diabet Med. 2019;36:1600–11.
Katon WJ, Simon G, Russo J, Von Korff M, Lin EHB, Ludman E, et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care. 2004;42:1222–9.
Egede LE, Ellis C, Grubaugh AL. The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes. Gen Hosp Psychiatry. 2009;31:422–7.
Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015;75:577–87.
Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007;30:2222–7.
Genis-Mendoza AD, González-Castro TB, Tovilla-Vidal G, Juárez-Rojop IE, Castillo-Avila RG, López-Narváez ML, et al. Increased levels of HbA1c in individuals with type 2 diabetes and depression: a Meta-analysis of 34 studies with 68,398 participants. Biomedicines. 2022;10:1919.
Brüne M, Linnenkamp U, Andrich S, Jaffan-Kolb L, Claessen H, Dintsios C-M, et al. Health Care Use and costs in individuals with diabetes with and without Comorbid Depression in Germany: results of the cross-sectional DiaDec Study. Diabetes Care. 2021;44:407–15.
Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol. 2019;56:631–50.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med J Br Diabet Assoc. 2006;23:1165–73.
Radloff LS, The CES-D, Scale. A self-report Depression Scale for Research in the General Population. Appl Psychol Meas. 1977;1:385–401.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.
Hamilton M, A RATING SCALE FOR, DEPRESSION. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
Beck AT. An inventory for Measuring Depression. Arch Gen Psychiatry. 1961;4:561.
Vilagut G, Forero CG, Barbaglia G, Alonso J. Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis. van der Feltz-Cornelis C, editor. PLOS ONE. 2016;11:e0155431.
Levis B, Benedetti A, Thombs BD. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.BMJ. 2019;l1476.
Khamseh ME, Baradaran HR, Javanbakht A, Mirghorbani M, Yadollahi Z, Malek M. Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran. BMC Psychiatry. 2011;11:61.
Zhang Y, Ting RZW, Lam MHB, Lam S-P, Yeung RO, Nan H et al. Measuring depression with CES-D in Chinese patients with type 2 diabetes: the validity and its comparison to PHQ-9. BMC Psychiatry [Internet]. 2015 [cited 2017 May 11];15. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538746/
Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia. 2006;49:469–77.
de Joode JW, van Dijk SEM, Walburg FS, Bosmans JE, van Marwijk HWJ, de Boer MR et al. Diagnostic accuracy of depression questionnaires in adult patients with diabetes: A systematic review and meta-analysis. Cheungpasitporn W, editor. PLOS ONE. 2019;14:e0218512.
Kvitkina T, Brune M, Chernyak N, Begun A, Andrich S, Linnenkamp U, et al. Protocol of the DiaDec-study: quality of life, health care utilisation and costs in patients with diabetes: the role of depression. J Diabetol Endocrinol. 2016;1:12–7.
Icks A, Haastert B, Trautner C, Giani G, Glaeske G, Hoffmann F. Incidence of lower-limb Amputations in the Diabetic compared to the non-diabetic Population. Findings from Nationwide Insurance Data, Germany, 2005–2007. Exp Clin Endocrinol Amp Diabetes. 2009;117:500–4.
Linnenkamp U, Gontscharuk V, Brüne M, Chernyak N, Kvitkina T, Arend W et al. Using statutory health insurance data to evaluate non-responsein a cross-sectional study on depression among patients withdiabetes in Germany. Int J Epidemiol. forthcoming
Lehmann V, Makine C, Karşıdağ C, Kadıoğlu P, Karşıdağ K, Pouwer F. Validation of the turkish version of the centre for epidemiologic Studies Depression Scale (CES-D) in patients with type 2 diabetes mellitus. BMC Med Res Methodol. 2011;11:109.
Maksimović S, Ziegenbein M, Machleidt W, Sieberer M. [Measurement invariance of the german version of the Center for Epidemiological Studies Depression Scale (CES-D 20) among males and females with and without a history of migration]. Psychiatr Prax. 2014;41:324–30.
Reddy P, Philpot B, Ford D, Dunbar JA. Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D. Br J Gen Pract J R Coll Gen Pract. 2010;60:e239–245.
Organisation for Economic Co-operation and Development (OECD). Classifying educational programmes: manual for ISCED-97 implementation in OECD countries | VOCEDplus, the international tertiary education and research database [Internet]. Paris: UNESCO Institute for Statistics; [cited 2017 May 4]. Available from: http://www.voced.edu.au/content/ngv:11701
Ware J, Kosinski M, Keller SD. A 12-Item short-form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.
Buchner F, Goepffarth D, Wasem J. The new risk adjustment formula in Germany: implementation and first experiences. Health Policy Amst Neth. 2013;109:253–62.
Chang H-Y, Weiner JP, Richards TM, Bleich SN, Segal JB. Validating the adapted diabetes complications Severity Index in Claims Data. Am J Manag Care Am J Manag Care. 2012;18:721–6.
Nationale VersorgungsLeitlinie (NVL) Unipolare Depression Langfassung. 2. Auflage, Version. 1, 2015. AWMF-Register-Nr.: nvl-005 [Internet]. Available from: https://www.dgppn.de/fileadmin/user_upload/_medien/download/pdf/kurzversion-leitlinien/S3-NVLdepression-lang_2015.pdf
IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes [Internet]. 2012 [cited 2017 Jul 26]. Available from: https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes
Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, et al. Elevated depression symptoms, Antidepressant Medicine Use, and risk of developing diabetes during the diabetes Prevention Program. Diabetes Care. 2008;31:420–6.
Meng R, Liu N, Yu C, Pan X, Lv J, Guo Y, et al. Association between major depressive episode and risk of type 2 diabetes: a large prospective cohort study in chinese adults. J Affect Disord. 2018;234:59–66.
Chen S, Zhang Q, Dai G, Hu J, Zhu C, Su L et al. Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis.Endocrine. 2016
Qiao Y, Liu S, Li G, Lu Y, Wu Y, Ding Y, et al. Role of depressive symptoms in cardiometabolic diseases and subsequent transitions to all-cause mortality: an application of multistate models in a prospective cohort study. Stroke Vasc Neurol. 2021;6:511–8.
Grobe TG, Kleine-Budde K, Bramesfeld A, Thom J, Bretschneider J, Hapke U. Prävalenzen von Depressionen bei Erwachsenen – eine vergleichende Analyse bundesweiter Survey- und Routinedaten. Gesundheitswesen. 2019;81:1011–7.
Hoffmann F, Icks A. Diabetes “epidemic” in Germany? A critical look at health insurance data sources. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc. 2012;120:410–5.